Gaming takes physician marketing to a new level

Share this article:
Medical marketers seeking new ways to reach physician audiences have been borrowing ideas from the world of video games in growing numbers over the last few months.

This marketing trend consists of the use of specially designed video games called medgames, which combine the entertainment thrills of a 3-D video game with the needs of promoting brand or disease awareness.

“Medgames, in essentially three minutes, describe a mechanism of action in a beautiful, sexy way that's going to get pharma marketers' message out and give sales reps something to play off of,” said Jeff Hazelton, founder and president of gaming firm BioLucid Productions.

During the 2006 Digestive Disease Week conference in Los Angeles approximately five medgames made their debut.

They included efforts behind AstraZeneca's Prilosec and a Crohn's disease awareness medgame created for Elan Pharmaceuticals by BioLucid.

Nearly 2,000 physicians, over the three days, waited in line to play the game, Hazelton said.
“The best thing from a marketing standpoint was that the game offered an opportunity to collect important information on doctors and the patients they treat, and to log how many physicians played,” Hazelton said.

The sky's the limit for med-gaming, Hazelton added.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...